tiprankstipranks
Valion Bio (VBIO)
NASDAQ:VBIO
US Market
VBIO
Valion Bio
RESEARCH TOOLSreports
Want to see VBIO full AI Analyst Report?

Valion Bio (VBIO) Income Statement

172 Followers

Valion Bio Income Statement

Last quarter (Q2 2026), Valion Bio's total revenue was $146.00K, a decrease of -148.34% from the same quarter last year. In Q2, Valion Bio's net income was $-2.60M. See Valion Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 24Dec 23Mar 23
Total Revenue
$ 0.00$ 1.18M$ 0.00$ 1.84M$ 1.26M
Gross Profit
$ 0.00$ 287.00K$ -352.00K$ 299.00K$ -46.00K
Operating Expenses
$ 7.90M$ 8.53M$ 4.06M$ 10.40M$ 5.59M
Depreciation and Amortization
$ 5.00K$ 182.00K$ 352.00K$ 174.00K$ 24.00K
EBITDA
$ -7.84M$ -8.06M$ -4.06M$ -9.92M$ -5.61M
Operating Income
$ -7.90M$ -8.24M$ -4.42M$ -10.10M$ -5.63M
Other Income/Expenses
$ -95.00K$ 1.00K$ -54.00K$ 2.00K$ -2.86M
Pretax Income
$ -7.99M$ -8.24M$ -4.47M$ -10.10M$ -8.49M
Net Income
$ -8.88M$ -8.24M$ -5.66M$ -10.10M$ -8.49M
Per Share Metrics
Basic EPS
$ -7.84$ -176.80$ -19.68$ -1.77K$ -4.13K
Diluted EPS
$ -7.84$ -176.80$ -19.68$ -1.77K$ -4.13K
Weighted Average Shares Outstanding
 1.16M 46.65K 287.37K 5.69K 2.05K
Weighted Average Shares Outstanding (Diluted)
 1.16M 46.65K 287.37K 5.69K 2.05K
Currency in USD

Valion Bio Earnings and Revenue History